These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 20160479

  • 21. The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.
    Pang MF, Lin KW, Peh SC.
    Cell Mol Biol Lett; 2009; 14(2):222-47. PubMed ID: 19082921
    [Abstract] [Full Text] [Related]

  • 22. Elevated expression of c-myc in lymphoblastoid cells does not support an Epstein-Barr virus latency III-to-I switch.
    Pajic A, Polack A, Staege MS, Spitkovsky D, Baier B, Bornkamm GW, Laux G.
    J Gen Virol; 2001 Dec; 82(Pt 12):3051-3055. PubMed ID: 11714983
    [Abstract] [Full Text] [Related]

  • 23. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.
    Vockerodt M, Tesch H, Kube D.
    Genes Immun; 2001 Dec; 2(8):433-41. PubMed ID: 11781710
    [Abstract] [Full Text] [Related]

  • 24. Induction of CD44 expression by the Epstein-Barr virus latent membrane protein LMP1 is associated with lymphoma dissemination.
    Walter J, Schirrmacher V, Mosier D.
    Int J Cancer; 1995 May 04; 61(3):363-9. PubMed ID: 7537255
    [Abstract] [Full Text] [Related]

  • 25. Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue.
    Bornkamm GW.
    Semin Cancer Biol; 2009 Dec 04; 19(6):351-65. PubMed ID: 19619654
    [Abstract] [Full Text] [Related]

  • 26. The curious case of the tumour virus: 50 years of Burkitt's lymphoma.
    Thorley-Lawson DA, Allday MJ.
    Nat Rev Microbiol; 2008 Dec 04; 6(12):913-24. PubMed ID: 19008891
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Epstein-Barr virus, the TCL-1 oncogene and Burkitt's lymphoma.
    Bell A, Rickinson AB.
    Trends Microbiol; 2003 Nov 04; 11(11):495-7. PubMed ID: 14607063
    [Abstract] [Full Text] [Related]

  • 29. Expression of Epstein-Barr virus-gene products in Burkitt's lymphoma in Northeast Brazil.
    Araujo I, Foss HD, Bittencourt A, Hummel M, Demel G, Mendonca N, Herbst H, Stein H.
    Blood; 1996 Jun 15; 87(12):5279-86. PubMed ID: 8652843
    [Abstract] [Full Text] [Related]

  • 30. Downregulation of the polyamine regulator spermidine/spermine N(1)-acetyltransferase by Epstein-Barr virus in a Burkitt's lymphoma cell line.
    Shi M, Gan YJ, Davis TO, Scott RS.
    Virus Res; 2013 Oct 15; 177(1):11-21. PubMed ID: 23891576
    [Abstract] [Full Text] [Related]

  • 31. Association between Epstein-Barr virus and Burkitt's lymphoma in Taiwan.
    Chao TY, Wang TY, Lee WH.
    Cancer; 1997 Jul 01; 80(1):121-8. PubMed ID: 9210717
    [Abstract] [Full Text] [Related]

  • 32. EBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma.
    Ruf IK, Rhyne PW, Yang H, Borza CM, Hutt-Fletcher LM, Cleveland JL, Sample JT.
    Curr Top Microbiol Immunol; 2001 Jul 01; 258():153-60. PubMed ID: 11443860
    [No Abstract] [Full Text] [Related]

  • 33. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
    Vockerodt M, Wei W, Nagy E, Prouzova Z, Schrader A, Kube D, Rowe M, Woodman CB, Murray PG.
    J Pathol; 2013 Aug 01; 230(4):399-409. PubMed ID: 23592216
    [Abstract] [Full Text] [Related]

  • 34. Epstein-Barr virus sustains Burkitt's lymphomas and Hodgkin's disease.
    Hammerschmidt W, Sugden B.
    Trends Mol Med; 2004 Jul 01; 10(7):331-6. PubMed ID: 15242681
    [Abstract] [Full Text] [Related]

  • 35. Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma.
    Cen O, Kannan K, Huck Sappal J, Yu J, Zhang M, Arikan M, Ucur A, Ustek D, Cen Y, Gordon L, Longnecker R.
    mSphere; 2018 Aug 22; 3(4):. PubMed ID: 30135222
    [Abstract] [Full Text] [Related]

  • 36. Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers.
    Bornkamm GW.
    Int J Cancer; 2009 Apr 15; 124(8):1745-55. PubMed ID: 19165855
    [Abstract] [Full Text] [Related]

  • 37. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.
    Swart R, Ruf IK, Sample J, Longnecker R.
    J Virol; 2000 Nov 15; 74(22):10838-45. PubMed ID: 11044134
    [Abstract] [Full Text] [Related]

  • 38. Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells.
    Rechsteiner MP, Berger C, Weber M, Sigrist JA, Nadal D, Bernasconi M.
    J Gen Virol; 2007 May 15; 88(Pt 5):1454-1459. PubMed ID: 17412973
    [Abstract] [Full Text] [Related]

  • 39. Role of Epstein-Barr virus in Burkitt's lymphoma.
    Takada K.
    Curr Top Microbiol Immunol; 2001 May 15; 258():141-51. PubMed ID: 11443859
    [Abstract] [Full Text] [Related]

  • 40. Difference of Epstein-Barr virus isolates from Japanese patients and African Burkitt's lymphoma cell lines based on the sequence of latent membrane protein 1.
    Kanai K, Satoh Y, Saiki Y, Ohtani H, Sairenji T.
    Virus Genes; 2007 Jan 15; 34(1):55-61. PubMed ID: 16917741
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.